JP2023505316A5 - - Google Patents

Info

Publication number
JP2023505316A5
JP2023505316A5 JP2022534275A JP2022534275A JP2023505316A5 JP 2023505316 A5 JP2023505316 A5 JP 2023505316A5 JP 2022534275 A JP2022534275 A JP 2022534275A JP 2022534275 A JP2022534275 A JP 2022534275A JP 2023505316 A5 JP2023505316 A5 JP 2023505316A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
compound according
hydrogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022534275A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505316A (ja
JP7699128B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/062893 external-priority patent/WO2021113365A1/en
Publication of JP2023505316A publication Critical patent/JP2023505316A/ja
Publication of JP2023505316A5 publication Critical patent/JP2023505316A5/ja
Application granted granted Critical
Publication of JP7699128B2 publication Critical patent/JP7699128B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022534275A 2019-12-06 2020-12-02 ナノマテリアル Active JP7699128B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962944735P 2019-12-06 2019-12-06
US62/944,735 2019-12-06
PCT/US2020/062893 WO2021113365A1 (en) 2019-12-06 2020-12-02 Nanomaterials

Publications (3)

Publication Number Publication Date
JP2023505316A JP2023505316A (ja) 2023-02-08
JP2023505316A5 true JP2023505316A5 (enExample) 2023-11-30
JP7699128B2 JP7699128B2 (ja) 2025-06-26

Family

ID=76209418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022534275A Active JP7699128B2 (ja) 2019-12-06 2020-12-02 ナノマテリアル

Country Status (7)

Country Link
US (2) US20210169804A1 (enExample)
EP (1) EP4069675A4 (enExample)
JP (1) JP7699128B2 (enExample)
KR (1) KR20220113737A (enExample)
AU (1) AU2020396940A1 (enExample)
CA (1) CA3160395A1 (enExample)
WO (1) WO2021113365A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3145913A1 (en) 2019-07-29 2021-02-04 James Everett Dahlman Nanomaterials containing constrained lipids and uses thereof
IL294318A (en) 2020-01-09 2022-08-01 Guide Therapeutics Llc Nanomaterials
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
EP4228658A4 (en) 2020-10-14 2025-02-19 George Mason Research Foundation, Inc. IONIZABLE LIPIDS AND METHODS FOR THE PRODUCTION AND USE THEREOF
EP4262818A4 (en) * 2020-12-21 2025-03-26 Beam Therapeutics Inc. NANOMATERIALS WITH CARBONATES
EP4281080A4 (en) 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
JP7698851B2 (ja) * 2021-12-16 2025-06-26 Jsr株式会社 組成物の純化方法
CN114436994B (zh) * 2022-01-26 2024-02-27 中国药科大学 金刚烷尾链脂质及其在细胞转染中的应用
WO2023230601A1 (en) 2022-05-27 2023-11-30 Beam Therapeutics Inc. Identification of nanoparticles for preferential tissue or cell targeting
WO2023250197A2 (en) * 2022-06-23 2023-12-28 Turn Biotechnologies, Inc. Lipid structures and compositions comprising same
CA3260437A1 (en) 2022-07-20 2024-01-25 Beam Therapeutics Inc. NANOMATERIALS INCLUDING TRIOLS
JP2025539561A (ja) * 2022-12-12 2025-12-05 コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー 新規な脂質化合物及びそれを含む脂質ナノ粒子組成物
AU2024279278A1 (en) 2023-05-31 2025-12-18 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
CN119490447A (zh) * 2023-08-17 2025-02-21 苏州星核迪赛生物技术有限公司 药物递送材料及其应用
WO2025076049A1 (en) * 2023-10-03 2025-04-10 Broadpharm Inc. Lipid compounds, lipid nanoparticles, and pharmaceutical compositions
WO2026035680A1 (en) 2024-08-06 2026-02-12 Kernal Biologics, Inc. Compositions and methods for delivery of agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL257307A (enExample) * 1959-10-28
US3686238A (en) * 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
DE102007029471A1 (de) 2007-06-20 2008-12-24 Novosom Ag Neue fakultativ kationische Sterole
EP3083556B1 (en) * 2013-12-19 2019-12-25 Novartis AG Lipids and lipid compositions for the delivery of active agents
EP3727362A4 (en) 2017-12-19 2021-10-06 PureTech LYT, Inc. MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES
CA3107481A1 (en) * 2018-08-02 2020-02-06 Puretech Lyt, Inc. Lipid prodrugs of pregnane neurosteroids and uses thereof
WO2020176856A1 (en) * 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of glucocorticoids and uses thereof
CA3130349A1 (en) * 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of jak inhibitors and uses thereof
WO2020176868A1 (en) * 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of btk inhibitors and uses thereof
CA3145913A1 (en) * 2019-07-29 2021-02-04 James Everett Dahlman Nanomaterials containing constrained lipids and uses thereof

Similar Documents

Publication Publication Date Title
JP2023505316A5 (enExample)
JP2023510778A5 (enExample)
AU2023200568C1 (en) Novel lipids and compositions for the delivery of therapeutics
JP5902197B2 (ja) Ｐｅｇ化脂質および薬剤送達のためのそれらの使用
JP2025181861A5 (enExample)
JP2021020928A (ja) 標的化脂質
AU2022268351A1 (en) Di-aliphatic substituted pegylated lipids
JP6077509B2 (ja) 改良されたアミノ脂質および核酸の送達方法
JP2012509273A5 (enExample)
EP3328439A1 (en) Multiligand agent for drug delivery
JP2024509906A5 (enExample)
ES2368300B1 (es) Derivados lipofílicos de ácidos nucleicos.
EA048677B1 (ru) Липиды и композиции для доставки лекарственных средств